| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 17,660 | $80 | $1.3M |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 44,270 | $30 | $1.2M |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 16,070 | $40 | $658.7K |
| 99282 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a straightforward level of medical decision making. | 9,500 | $70 | $655.2K |
| 87430 | The lab analyst performs an assay to evaluate the patient’s sample for antigens to Streptococcus, group A, using an immunoassay method, such as EIA. | 2,770 | $220 | $599K |
| 99281 | The provider sees a patient for the lowest level emergency department visit. | 4,330 | $100 | $428.2K |
| J7030 | Infusion, normal saline solution , 1000 cc | 1,730 | $190 | $333.3K |
| 87636 | The lab analyst performs the technical steps to detect and differentiate severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), influenza A, and influenza B using a multiplex amplified nucleic… | 3,380 | $80 | $273.9K |
| 87077 | The lab analyst performs additional tests on a presumptively identified aerobic isolate to definitively, which means more specifically, identify the organism, such as to the level of species. | 3,380 | $70 | $226.1K |
| 87804 | The analyst performs an immunoassay with direct optical, meaning visual, observation to detect influenza, also called flu, in a patient sample, typically a throat or nasal swab or nasal washings. | 2,770 | $70 | $182.6K |